Works matching IS 14765810 AND DT 2012 AND VI 10 AND IP 3

Results: 9

European consensus document on mast cell tumours in dogs and cats.
Published in:
Veterinary & Comparative Oncology, 2012, v. 10, n. 3, p. e1, doi. 10.1111/j.1476-5829.2012.00341.x
By:
- Blackwood, L.;
- Murphy, S.;
- Buracco, P.;
- De Vos, J. P.;
- De Fornel-Thibaud, P.;
- Hirschberger, J.;
- Kessler, M.;
- Pastor, J.;
- Ponce, F.;
- Savary-Bataille, K.;
- Argyle, D. J.
Publication type:
Article
Preliminary evidence for biologic activity of toceranib phosphate (Palladia<sup>®</sup>) in solid tumours Preliminary evidence for biologic activity of toceranib phosphate (Palladia<sup>®</sup>) in solid tumours.
Published in:
Veterinary & Comparative Oncology, 2012, v. 10, n. 3, p. 194, doi. 10.1111/j.1476-5829.2011.00275.x
By:
- London, C.;
- Mathie, T.;
- Stingle, N.;
- Clifford, C.;
- Haney, S.;
- Klein, M. K.;
- Beaver, L.;
- Vickery, K.;
- Vail, D. M.;
- Hershey, B.;
- Ettinger, S.;
- Vaughan, A.;
- Alvarez, F.;
- Hillman, L.;
- Kiselow, M.;
- Thamm, D.;
- Higginbotham, M. L.;
- Gauthier, M.;
- Krick, E.;
- Phillips, B.
Publication type:
Article
Primary frontal sinus squamous cell carcinoma in three dogs treated with piroxicam combined with carboplatin or toceranib.
Published in:
Veterinary & Comparative Oncology, 2012, v. 10, n. 3, p. 206, doi. 10.1111/j.1476-5829.2011.00292.x
By:
- de Vos, J.;
- Ramos Vega, S.;
- Noorman, E.;
- de Vos, P.
Publication type:
Article
Phosphotyrosine enrichment identifies focal adhesion kinase and other tyrosine kinases for targeting in canine hemangiosarcoma.
Published in:
Veterinary & Comparative Oncology, 2012, v. 10, n. 3, p. 214, doi. 10.1111/j.1476-5829.2012.00325.x
By:
- Marley, K.;
- Maier, C. S.;
- Helfand, S. C.
Publication type:
Article
Receptor tyrosine kinase inhibitors: molecularly targeted drugs for veterinary cancer therapy Receptor tyrosine kinase inhibitors: molecularly targeted drugs for veterinary cancer therapy.
Published in:
Veterinary & Comparative Oncology, 2012, v. 10, n. 3, p. 163, doi. 10.1111/j.1476-5829.2012.00342.x
By:
- Bavcar, S.;
- Argyle, D. J.
Publication type:
Article
In vitro effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine hemangiosarcoma cell lines In vitro effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine hemangiosarcoma cell lines*.
Published in:
Veterinary & Comparative Oncology, 2012, v. 10, n. 3, p. 223, doi. 10.1111/j.1476-5829.2012.00335.x
By:
- Lyles, S. E.;
- Milner, R. J.;
- Kow, K.;
- Salute, M. E.
Publication type:
Article
Safety evaluation of combination vinblastine and toceranib phosphate (Palladia®) in dogs: a phase I dose-finding study Safety evaluation of combination vinblastine and toceranib phosphate (Palladia®) in dogs: a phase I dose-finding study.
Published in:
Veterinary & Comparative Oncology, 2012, v. 10, n. 3, p. 174, doi. 10.1111/j.1476-5829.2011.00261.x
By:
- Robat, C.;
- London, C.;
- Bunting, L.;
- McCartan, L.;
- Stingle, N.;
- Selting, K.;
- Kurzman, I.;
- Vail, D. M.
Publication type:
Article
Tyrosine kinase inhibitor special issue Tyrosine kinase inhibitor special issue.
Published in:
Veterinary & Comparative Oncology, 2012, v. 10, n. 3, p. 161, doi. 10.1111/j.1476-5829.2012.00339.x
By:
- Thamm, Douglas H.
Publication type:
Article
Safety evaluation of combination toceranib phosphate (Palladia®) and piroxicam in tumour-bearing dogs (excluding mast cell tumours): a phase I dose-finding study Safety evaluation of combination toceranib phosphate (Palladia®) and piroxicam in tumour-bearing dogs (excluding mast cell tumours): a phase I dose-finding study
Published in:
Veterinary & Comparative Oncology, 2012, v. 10, n. 3, p. 184, doi. 10.1111/j.1476-5829.2011.00265.x
By:
- Chon, E.;
- McCartan, L.;
- Kubicek, L. N.;
- Vail, D. M.
Publication type:
Article